Sign in

Dr. Samer Haj-Yehia

Director at LemonadeLemonade
Board

About Dr. Samer Haj‑Yehia

Independent director since November 2023; age 55; currently Class II nominee for term through 2028. Former Group Executive Chairman of Bank Leumi (2019–Oct 2023), with prior investment management/trading experience in the US (including Fidelity). Academic roles include teaching finance/fintech at Reichman University; degrees: Ph.D. (MIT); MBA (summa cum laude), LLB, MA (magna cum laude) in economics, BA (magna cum laude) in accounting (Hebrew University); CFA charterholder .

Past Roles

OrganizationRoleTenureCommittees/Impact
Bank LeumiGroup Executive Chairman2019–Oct 2023Led tech transformation; improved efficiency, income and profitability

External Roles

OrganizationRoleTenureNotes
Fidelity (US)Investment management/tradingNot disclosedBiography notes prior US finance roles
Reichman UniversityLecturer in finance/fintechCurrentGuest speaker at international conferences

Board Governance

  • Independence: Board determined Dr. Haj‑Yehia is independent under NYSE rules .
  • Committee assignments and expertise:
    • Audit Committee: Chair; Board designated him an “audit committee financial expert” .
    • Compensation Committee: Member .
    • Nominating & Corporate Governance: Not a member .
  • Attendance: Board met six times in 2024; each director attended at least 75% of Board and applicable committee meetings .
  • Executive sessions: Non‑management directors meet at least twice per year; Lead Independent Director (Michael Eisenberg) presides .
  • Board structure: Classified into three staggered classes; he is Class II and up for re‑election through the 2028 annual meeting .

Fixed Compensation

Metric20232024
Cash fees (annual)$6,128 $55,000
Equity grant fair value$175,002 (initial RSU) $150,004 (annual RSU)
Total director compensation$181,130 $205,004

Policy detail: Non‑employee directors receive a $20,000 annual cash retainer; additional cash for committee roles (Audit chair $20,000; Audit member $7,500; Compensation chair $10,000; Compensation member $5,000; Nominating chair $7,500; Nominating member $3,500). RSUs: initial $175,000 vest in three equal annual installments; annual RSUs of $150,000 vest on first anniversary; vesting accelerates upon change in control .

Performance Compensation

Equity instrumentGrant value (indicative)VestingPerformance linkageChange‑of‑control treatment
Initial RSU grant$175,000 3 equal annual installments None disclosed (time‑based) Accelerated vesting
Annual RSU grant$150,000 1‑year cliff None disclosed (time‑based) Accelerated vesting

Company clawback policy applies to incentive‑based compensation for officers under Rule 10D‑1; director equity awards are time‑based and not tied to disclosed performance metrics .

Other Directorships & Interlocks

CompanyRoleStatusInterlock notes
None disclosed (public companies)Compensation Committee interlocks: none; no insider participation on cross‑company boards by LMND executives in 2024 .

Expertise & Qualifications

  • Audit committee financial expert designation; deep banking, risk, and fintech background .
  • Advanced academic credentials (MIT Ph.D.; multiple Hebrew University degrees); CFA .
  • Governance competencies: chairs Audit; member Compensation; independence affirmed .

Equity Ownership

MetricAs of Apr 10, 2025
Beneficial ownership (shares)12,872 (3,641 common + 9,231 RSUs vesting within 60 days)
Ownership % of shares outstanding<1% (“*” in table)
Unvested director stock awards (year‑end)10,924 (Dec 31, 2023) ; 16,514 (Dec 31, 2024)

Alignment policies:

  • Hedging/pledging of Company stock prohibited for directors, officers and employees under Insider Trading Compliance Policy .

Governance Assessment

  • Strengths:
    • Independent director with audit chair role and “financial expert” designation—supports robust financial reporting oversight .
    • Attendance threshold met; engaged across 2024 cycle .
    • Director pay structure predominantly equity via RSUs with standard change‑in‑control acceleration; avoids complex option repricing or aggressive cash incentives .
    • No related‑party transactions disclosed involving Dr. Haj‑Yehia; related person transactions are reviewed/approved under a formal Audit Committee policy .
    • Company policies prohibit hedging/pledging; clawback adopted for erroneous incentive pay recovery (officers) .
  • Watch items / potential investor signals:
    • Small ownership stake (<1%); while typical for non‑employee directors, alignment may rely on ongoing RSU grants rather than significant personal holdings .
    • Classified board structure can limit shareholder influence on board refresh; though common in insurance, it may be viewed as entrenchment risk by some investors .
    • Significant external time commitments historically (academic/industry speaking) noted—monitor continued board engagement and audit chair workload given LMND’s growth and reinsurance complexities .

Compensation Committee Analysis

  • Composition: Michael Eisenberg (Chair), Dr. Samer Haj‑Yehia, Maria Angelidis‑Smith—each independent and non‑employee .
  • Consultant: Aon Human Capital Solutions engaged; Committee determined no conflicts; advises on executive and director compensation benchmarking .
  • Interlocks: None; no LMND executive served on another public company’s compensation committee with reciprocal ties in 2024 .
  • Say‑on‑Pay: 2024 approval ~87.5% “For,” improved from 2023—suggests shareholder acceptance of pay design trend .

Related Party Transactions (Conflict Checks)

  • Audit Committee reviews/approves related person transactions under formal policy; no director may participate in a transaction where they are the related person .
  • Disclosed transactions largely pertain to investor registration rights (e.g., SoftBank) and the Lemonade Foundation (CEO/President act as its board members); no items involve Dr. Haj‑Yehia .

RED FLAGS

  • None specific to Dr. Haj‑Yehia in filings: no related‑party transactions, no hedging/pledging, no Section 16(a) delinquencies cited for him (late filings noted for two LMND officers only) .
  • Structural red flag consideration: classified board persists .

Summary Tables

Committee assignments and roles

CommitteeRole2024–2025 Status
AuditChair; Financial ExpertActive; 4 meetings in 2024
CompensationMemberActive
Nominating & Corporate GovernanceNot a member

Director compensation trend

Component20232024
Cash fees$6,128 $55,000
RSU grant fair value$175,002 $150,004
Total$181,130 $205,004

Unvested director stock awards (year‑end)

Metric2023 YE2024 YE
Unvested RSUs (count)10,924 16,514

Beneficial ownership snapshot

MetricApr 10, 2025
Shares beneficially owned12,872 (3,641 common + 9,231 RSUs vesting ≤60 days)
Ownership %<1%